{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:31Z","timestamp":1707525391869},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,9]]},"DOI":"10.7759\/cureus.48564","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T14:59:10Z","timestamp":1699541950000},"source":"Crossref","is-referenced-by-count":0,"title":["Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients"],"prefix":"10.7759","author":[{"given":"Asaf","family":"Syed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umer Bin","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihteshamul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenish","family":"Naz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsalan","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2077","article-title":"Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment","volume":"139","author":"Rogan MP","year":"2011","unstructured":"Rogan MP, Stoltz DA, Hornick DB. Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment. Chest. 2011, 139:1480-90. 10.1378\/chest.10-2077","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-011-0113-6","article-title":"The cystic fibrosis neutrophil: a specialized yet potentially defective cell","volume":"59","author":"Hayes E","year":"2011","unstructured":"Hayes E, Pohl K, McElvaney NG, Reeves EP. The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz). 2011, 59:97-112. 10.1007\/s00005-011-0113-6","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12314","article-title":"Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients","volume":"277","author":"Amaral MD","year":"2015","unstructured":"Amaral MD. Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients. J Intern Med. 2015, 277:155-66. 10.1111\/joim.12314","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(12)70057-7","article-title":"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect","volume":"1","author":"Boyle MP","year":"2013","unstructured":"Boyle MP, De Boeck K. A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. Lancet Respir Med. 2013, 1:158-63. 10.1016\/S2213-2600(12)70057-7","journal-title":"Lancet Respir Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03540-9","article-title":"Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations","volume":"77","author":"Lara-Reyna S","year":"2020","unstructured":"Lara-Reyna S, Holbrook J, Jarosz-Griffiths HH, Peckham D, McDermott MF. Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations. Cell Mol Life Sci. 2020, 77:4485-503. 10.1007\/s00018-020-03540-9","journal-title":"Cell Mol Life Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/bbrj.bbrj_81_17","article-title":"Geographical distribution of cystic fibrosis; the past 70 years of data analysis","volume":"1","author":"Mirtajani SB","year":"2017","unstructured":"Mirtajani SB, Farnia P, Hassanzad M, Ghanavi J, Farnia P, Velayati AA. Geographical distribution of cystic fibrosis; the past 70 years of data analysis. Biomed Biotechnol Res J. 2017, 1:105-12. 10.4103\/bbrj.bbrj_81_17","journal-title":"Biomed Biotechnol Res J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1109\/ISMAR-Adjunct.2019.00044","article-title":"Breathe to dive: exploring a virtual reality game for treatment of cystic fibrosis","author":"Wetzel R","year":"2019","unstructured":"Wetzel R, Kreienb\u00fchl T. Breathe to dive: exploring a virtual reality game for treatment of cystic fibrosis. IEEE. 2019, 412-6. 10.1109\/ISMAR-Adjunct.2019.00044","journal-title":"IEEE"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/prcm.prcm_5_20","article-title":"Cystic fibrosis in Asia","volume":"1","author":"Ahmed S","year":"2020","unstructured":"Ahmed S, Cheok G, Goh AE, et al.. Cystic fibrosis in Asia. J Paediatr Respirol Crit Care. 2020, 1:8. 10.4103\/prcm.prcm_5_20","journal-title":"J Paediatr Respirol Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell SC","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H, et al.. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020, 8:65-124. 10.1016\/S2213-2600(19)30337-6","journal-title":"Lancet Respir Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-020-00150-z","article-title":"Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility","volume":"5","author":"Cheema H","year":"2020","unstructured":"Cheema H, Bertoli-Avella AM, Skrahina V, et al.. Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility. NPJ Genom Med. 2020, 5:44. 10.1038\/s41525-020-00150-z","journal-title":"NPJ Genom Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ahg.12308","article-title":"Consanguinity: a blessing or menace at population level?","volume":"83","author":"Bhinder MA","year":"2019","unstructured":"Bhinder MA, Sadia H, Mahmood N, et al.. Consanguinity: a blessing or menace at population level?. Ann Hum Genet. 2019, 83:214-9. 10.1111\/ahg.12308","journal-title":"Ann Hum Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2009.04.003","article-title":"Patient-reported respiratory symptoms in cystic fibrosis","volume":"8","author":"Goss CH","year":"2009","unstructured":"Goss CH, Edwards TC, Ramsey BW, Aitken ML, Patrick DL. Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros. 2009, 8:245-52. 10.1016\/j.jcf.2009.04.003","journal-title":"J Cyst Fibros"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12924","article-title":"Suspecting non-cystic fibrosis bronchiectasis: what the busy primary care clinician needs to know","volume":"71","author":"Maselli DJ","year":"2017","unstructured":"Maselli DJ, Amalakuhan B, Keyt H, Diaz AA. Suspecting non-cystic fibrosis bronchiectasis: what the busy primary care clinician needs to know. Int J Clin Pract. 2017, 71:e12924. 10.1111\/ijcp.12924","journal-title":"Int J Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4187\/aarc0443","article-title":"Pulmonary complications of cystic fibrosis","volume":"54","author":"Flume PA","year":"2009","unstructured":"Flume PA. Pulmonary complications of cystic fibrosis. Respir Care. 2009, 54:618-27. 10.4187\/aarc0443","journal-title":"Respir Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran A","year":"2010","unstructured":"Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, Marshall BC, Slovis B. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care. 2010, 33:2677-83. 10.2337\/dc10-1279","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107845","article-title":"Effect of CFTR modulator therapy on cystic fibrosis-related diabetes","volume":"35","author":"Gaines H","year":"2021","unstructured":"Gaines H, Jones KR, Lim J, Medhi NF, Chen S, Scofield RH. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes. J Diabetes Complications. 2021, 35:107845. 10.1016\/j.jdiacomp.2020.107845","journal-title":"J Diabetes Complications"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2010.10.002","article-title":"Cystic fibrosis in Chilean patients: analysis of 36 common CFTR gene mutations","volume":"10","author":"Lay-Son G","year":"2011","unstructured":"Lay-Son G, Puga A, Astudillo P, Repetto GM. Cystic fibrosis in Chilean patients: analysis of 36 common CFTR gene mutations. J Cyst Fibros. 2011, 10:66-70. 10.1016\/j.jcf.2010.10.002","journal-title":"J Cyst Fibros"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.04.044","article-title":"CFTR gene mutations and polymorphism are associated with non-obstructive azoospermia: from case-control study","volume":"626","author":"Jiang L","year":"2017","unstructured":"Jiang L, Jin J, Wang S, Zhang F, Dai Y, Shi L, Zhang S. CFTR gene mutations and polymorphism are associated with non-obstructive azoospermia: from case-control study. Gene. 2017, 626:282-9. 10.1016\/j.gene.2017.04.044","journal-title":"Gene"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2019.73.118-120","article-title":"Cystic fibrosis gene mutation frequency among a group of suspected children in King Hussein Medical Center","volume":"73","author":"Al-Abadi B","year":"2019","unstructured":"Al-Abadi B, Al-Hiary M, Khasawneh R, et al.. Cystic fibrosis gene mutation frequency among a group of suspected children in King Hussein Medical Center. Med Arch. 2019, 73:118-20. 10.5455\/medarh.2019.73.118-120","journal-title":"Med Arch"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2020-0275","article-title":"Frequency of CFTR variants in southern Brazil and indication for modulators therapy in patients with cystic fibrosis","volume":"45","author":"Lima ED","year":"2021","unstructured":"Lima ED, Pezzin LS, Fensterseifer AC, Pinto LA. Frequency of CFTR variants in southern Brazil and indication for modulators therapy in patients with cystic fibrosis. Genet Mol Biol. 2021, 45:e20200275. 10.1590\/1678-4685-GMB-2020-0275","journal-title":"Genet Mol Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/191816-insights-into-cystic-fibrosis-gene-mutation-frequency-clinical-findings-and-complications-among-pakistani-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:57Z","timestamp":1707509457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/191816-insights-into-cystic-fibrosis-gene-mutation-frequency-clinical-findings-and-complications-among-pakistani-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.48564","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,9]]}}}